Cargando…
Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms
A growing body of evidence suggests that a subset of cells within tumors are resistant to conventional treatment modalities and may be responsible for disease recurrence. These cells are called cancer stem cells (CSC), which share properties with normal stem cells including self-renewal, pluripotenc...
Autores principales: | Chaurasiya, Shyambabu, Chen, Nanhai G., Warner, Susanne G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923379/ https://www.ncbi.nlm.nih.gov/pubmed/29671772 http://dx.doi.org/10.3390/cancers10040124 |
Ejemplares similares
-
Oncolytic Virotherapy for Cancer: Clinical Experience
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021) -
Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges
por: Chaurasiya, Shyambabu, et al.
Publicado: (2020) -
From Benchtop to Bedside: A Review of Oncolytic Virotherapy
por: Choi, Audrey H., et al.
Publicado: (2016) -
A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection
por: O’Leary, Michael P., et al.
Publicado: (2018) -
Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose
por: O’Leary, Michael P., et al.
Publicado: (2018)